Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by RedHill Biopharma Ltd RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib April 11, 2022 From RedHill Biopharma Ltd Via AccessWire Tickers RDHL RedHill Announces Additional Insider Buying December 15, 2021 From RedHill Biopharma Ltd Via AccessWire Exposures COVID-19 Tickers RDHL RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori December 09, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma Ltd - Opaganib MoA Not Impacted by Omicron Mutations December 06, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma Ltd Announces Talicia: Consistent Efficacy Irrespective of BMI December 02, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill’s Movantik Added To Medicare Formulary December 01, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Reports 3Q/2021 Financial Results November 30, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma Ltd Announces RedHill: LPI in Part A of RHB-107 P2/3 COVID Study November 15, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill November 08, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma Presents New Talicia(R) and Movantik(R) Data Analyses at ACG 2021 October 25, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma Announces Insider Buying October 18, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma Ltd Announces New U.S. Patent for RedHill's Talicia for H.pylori October 12, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma Ltd Announces Talicia(R) added to Medi-Cal CDL October 06, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients October 04, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Death Intellectual Property Regulatory Compliance Exposures COVID-19 Death Intellectual Property Tickers RDHL RHB-107 P2/3 COVID-19 Study South Africa Approval September 13, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis September 07, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma Ltd Announces New Movantik Analyses at PAINWeek September 07, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill to Present at HCW & Cantor Conferences September 02, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Reports Second Quarter 2021 Results August 26, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Supply Chain Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma Ltd Announces RedHill's Opaganib Strong Delta Variant Inhibition August 26, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Announces Two New U.S. Patents August 23, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Settles Movantik(R) Apotex Patent Litigation July 22, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal RedHill Extends Talicia Commercial Coverage July 20, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL RedHill Biopharma Ltd Announces RedHill Biopharma Announces Last Patient Out July 19, 2021 From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers RDHL Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.